1-6 of 6
Rebecca Klisovic, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ratify (Alliance 10603): Prognostic Impact of FLT3 tyrosine Kinase Domain (TKD) and NPM1 Mutation Status in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Treated with Midostaurin or Placebo Plus Standard Chemotherapy

Maria Teresa Voso, Richard A. Larson, MD, Thomas Prior, Guido Marcucci, Dan Jones, MD PhD, Jürgen Krauter, MD, Michael Heuser, MD, Serena Lavorgna, PhD, Josep Nomdedeu, MD PhD, Susan M. Geyer, PhD, Rebecca Klisovic, MD, Andrew H Wei, MBBS, PhD, Jorge Sierra, MD, Miguel A. Sanz, MD, Joseph M. Brandwein, MD FRCPC, Theo M de Witte, MD, Joop H. Jansen, Dietger Niederweiser, Frederick R. Appelbaum, MD, Bruno C. Medeiros, MD, Martin S. Tallman, MD, Richard F. Schlenk, MD, Arnold Ganser, MD, Sergio Amadori, MD, Yuan Cheng, PhD, Insa Gathmann, Eva Tiecke, PhD, Christian Thiede, MD, Konstanze Döhner, MD, Hartmut Döhner, MD, Richard M. Stone, MD, Clara D. Bloomfield, MD, Francesco Lo-Coco, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2668.
https://doi.org/10.1182/blood-2018-99-114318
Published: 2018
Journal Articles

Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with Newly Diagnosed Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia

Anjali S. Advani, MD, Anna Moseley, M.S., Kristen Marie O'Dwyer, MD, Brent Wood, MDPhD, Min Fang, MDPhD, Matthew J. Wieduwilt, MD PhD, Ibrahim Aldoss, MD, Jae H. Park, MD, Rebecca Klisovic, MD, Maria R. Baer, MD, Wendy Stock, MD, Rupali Bhave, MD, Megan Othus, PhD, Mark R. Litzow, MD, Richard M. Stone, MD, Harry P. Erba, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 33.
https://doi.org/10.1182/blood-2018-99-111992
Published: 2018
Journal Articles

Phase I Study Of The Combination Of Midostaurin, Bortezomib and Chemotherapy In Relapsed/Refractory Acute Myeloid Leukemia (AML): Targeting Aberrant Tyrosine Kinase Activity

Alison R Walker, MD, Hongyan Wang, PhD, Rebecca Klisovic, MD, Katherine Walsh, MD, Sumithira Vasu, MBBS, Ramiro Garzon, MD, Steven M. Devine, MD, Amy Drake, William Blum, MD, Guido Marcucci, MD
Journal: Blood
Blood (2013) 122 (21): 3966.
https://doi.org/10.1182/blood.V122.21.3966.3966
Published: 2013
Journal Articles

Preliminary Results of a Phase II Study of Low Dose Decitabine as a Single Agent in Older Patients (age≥60) with Previously Untreated Acute Myeloid Leukemia (AML)

William Blum, MD, Rebecca Klisovic, MD, Shujun Liu, PhD, Ramiro Garzon, MD, Cheryl Kefauver, RN, Zhongfa Liu, PhD, Jon Mickle, CNP, Hollie Devine, CNP, Steve Devine, MD, Michael R Grever, MD, Kenneth K Chan, PhD, Miguel Villalona-Calero, MD, John C. Byrd, MD, Guido Marcucci, MD
Journal: Blood
Blood (2008) 112 (11): 2957.
https://doi.org/10.1182/blood.V112.11.2957.2957
Published: 2008
Journal Articles

High Rates of Early Donor Chimerism and Low Risk of Chronic GVHD Can Be Achieved in Poor Risk Patients Undergoing Unrelated Donor Stem Cell Transplantation Using a Reduced Intensity Conditioning Regimen Incorporating Fludarabine, Busulfan, and Rabbit ATG.

Mehdi Hamadani, MD, Patrick Elder, Farrukh Awan, David Krugh, William Blum, MD, Thomas Lin, MD, PhD, Leslie Andritsos, MD, Thomas Bechtel, Kristie Blum, MD, Rebecca Klisovic, MD, Steven M. Devine, MD
Journal: Blood
Blood (2007) 110 (11): 5080.
https://doi.org/10.1182/blood.V110.11.5080.5080
Published: 2007
Journal Articles

Imatinib Mesylate-Induced Complete Cytogenetic Response in Acute Myeloid Leukemia with t(5;12)(q33;p13).

William Blum, MD, Guido Marcucci, MD, Hollie Devine, CNP, Rebecca Klisovic, MD
Journal: Blood
Blood (2006) 108 (11): 4414.
https://doi.org/10.1182/blood.V108.11.4414.4414
Published: 2006